CANCER DISCOVERY ADVISORY GROUP |
|||
Name |
Institution |
Position/Area of expertise/interest |
Date of Appointment (new group formed March 2019) |
Professor Aras Kadioglu (Chairman) |
University of Liverpool |
Professor of Bacterial Pathogenesis Immunology/Pneumococcal pathogenesis |
March 2019 |
Professor Kevin Ryan (Vice chair) |
The Beatson Institute |
Professor of Cancer Research Regulation of programmed cell death/chemo resistance/development of proteins to control cell death and chemo sensitivity |
March 2019 |
Dr Simon Cook |
The Babraham Institute
|
Head of Laboratory. Biochemist and molecular biologist/interest in signal transduction, cell biology, cell senescence and molecular oncology |
March 2019 |
Dr Nikki Copeland |
Lancaster University
|
Lecturer in Biomedicine DNA replication/Chromosomal aberrations |
March 2019 |
Dr Rita Cha |
Bangor University |
Senior Lecturer in Biomedical Sciences (Cancer Cell Signalling) Molecular and basis of ATM/ATR function/ ATM/ATR signalling in dNTP production, genome stability, and cancer cell metabolism/DNA damage- and nutrient-signalling. |
March 2019 |
Dr Joe Sacco
|
University of Liverpool |
Consultant in Medical Oncology/Molecular and Clinical Medicine Melanoma/Head and Neck Cancer/ Deubiquitylating |
March 2019 |
Prof Graham Pockley |
Nottingham Trent University |
On sabbatical currently |
March 2019 |
Prof Christopher Twelves
|
Leeds University |
Professor of Clinical Cancer Pharmacology and Oncology Clinical oncology interests= colorectal and breast cancer/Experimental drug development |
March 2019 |
Dr Spencer Collis |
University of Sheffield |
Reader in Genome Stability. Cellular responses to DNA damage involve the orchestration of cell cycle checkpoints and DNA repair factors, which are rapidly activated and mobilised to sites of DNA damage. |
March 2019 |
Dr Catherine Green |
University of Oxford |
Associate Professor Head of Core in Chromosome Dynamic. Cancer biology and protein science and structural biology. |
March 2019 |
Dr John Marshall |
Lay representative |
|
|
Ratio of independence 6/12 PPI x1 |
- Meets annually to review the Cancer Discovery call
- Independence increased as this is a regionally focused call